Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-4-12
pubmed:abstractText
To assess the mechanisms of action of phenylbutyrate (PB), an investigational chemotherapeutic agent for prostate cancer (PCa), in apoptosis induction in PCa cell lines in vitro.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0884-6812
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
45-54
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10696460-Androgens, pubmed-meshheading:10696460-Annexin A5, pubmed-meshheading:10696460-Antigens, CD95, pubmed-meshheading:10696460-Antineoplastic Agents, pubmed-meshheading:10696460-Apoptosis, pubmed-meshheading:10696460-Biological Markers, pubmed-meshheading:10696460-Dose-Response Relationship, Drug, pubmed-meshheading:10696460-Fluorescent Antibody Technique, pubmed-meshheading:10696460-Gene Expression, pubmed-meshheading:10696460-Humans, pubmed-meshheading:10696460-In Situ Nick-End Labeling, pubmed-meshheading:10696460-Male, pubmed-meshheading:10696460-Phenylbutyrates, pubmed-meshheading:10696460-Prostatic Neoplasms, pubmed-meshheading:10696460-Proto-Oncogene Proteins, pubmed-meshheading:10696460-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:10696460-Tumor Cells, Cultured, pubmed-meshheading:10696460-Tumor Suppressor Protein p53, pubmed-meshheading:10696460-bcl-2-Associated X Protein
pubmed:year
2000
pubmed:articleTitle
Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines.
pubmed:affiliation
UroCor, Inc., Oklahoma City, Oklahoma 73104, USA. ang@uroor.com
pubmed:publicationType
Journal Article, Comparative Study